Librax (Chlordiazepoxide, Clidinium Bromide)

Chlordiazepoxide, the active ingredient in Librax, is a benzodiazepine presented as an oral tablet for oral use. Together with the anticholinergic clidinium bromide, the combination treats anxiety and reduces gastrointestinal spasm in adult patients.

GNH USA supplies Librax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for global distribution.

Librax combines a benzodiazepine and an anticholinergic to address disorders of the central nervous system and the gastrointestinal tract.

- Anxiety disorders: reduces excessive nervousness and tension in adult patients. - Irritable bowel syndrome: alleviates abdominal cramping and discomfort. - Peptic ulcer disease: diminishes ulcer‑related pain by relaxing gastric musculature. - Gastrointestinal spasm: lessens spasmodic contractions and associated pain.

Librax may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects: - Drowsiness: feeling of sleepiness or reduced alertness. - Dry mouth: decreased salivation causing a dry oral cavity. - Constipation: slowed intestinal transit leading to hard stools. - Blurred vision: temporary visual disturbance.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing that may require medical attention. - Severe hypotension: marked drop in blood pressure causing dizziness or fainting. - Paradoxical agitation: unexpected increase in anxiety or restlessness.

Before prescribing Librax, consider the following precautions to ensure safe use.

- Assess hepatic function: dose may need adjustment in patients with liver impairment. - Evaluate for dependence: benzodiazepine component can cause tolerance with prolonged use. - Monitor elderly patients: increased sensitivity to sedative effects and fall risk. - Avoid abrupt discontinuation: tapering is recommended to prevent withdrawal symptoms. - Contraindicated in acute narrow‑angle glaucoma: anticholinergic effect may worsen intra‑ocular pressure. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Librax can interact with other medicines; awareness of key interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Opioids: combined CNS depression may lead to respiratory failure. - Other benzodiazepines: additive sedative effects increase risk of profound drowsiness. - Anticholinergic agents: excessive anticholinergic load can cause severe dry mouth, urinary retention, and constipation.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may enhance serotonergic activity and increase sedation. - Antihistamines: additive anticholinergic effects may exacerbate dry mouth and blurred vision. - Alcohol: concurrent use can intensify sedation and impair coordination.